Peer-reviewedCC BY 4.0Research and Practice in Thrombosis and Haemostasis
Assessment of the residual bleeding burden in hemophilia B on factor IX prophylaxis
- 1University Hospital Frankfurt, Frankfurt, Germany
Related
- PO083 | WOMEN AND HEMOPHILIA: ASSESSMENT OF THE BLEEDING PHENOTYPE – ANALYSIS OF THE BRESCIA COHORT
- Outcomes of hemophilia A in children under primary and secondary prophylaxis: results from the HEMFIL Cohort Study
- Practical Pathological Assessment of Residual Cancer Burden (RCB) After Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Invasive Breast Carcinoma: A Case Report.
- Concizumab for the management of heavy menstrual bleeding in a woman with mild hemophilia A.
- Denecimig (Mim8) prophylaxis over 52 weeks in adolescents and adults with hemophilia A: FRONTIER2 extension study
BibTeX
@article{miesbach2026assessment,
title = {{Assessment of the residual bleeding burden in hemophilia B on factor IX prophylaxis}},
author = {Wolfgang Miesbach},
journal = {Research and Practice in Thrombosis and Haemostasis},
year = {2026},
month = oct,
doi = {10.1016/j.rpth.2026.107007},
url = {https://doi.org/10.1016/j.rpth.2026.107007},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Assessment of the residual bleeding burden in hemophilia B on factor IX prophylaxis
AU - Wolfgang Miesbach
PY - 2026
DA - 2026/10/09
JO - Research and Practice in Thrombosis and Haemostasis
DO - 10.1016/j.rpth.2026.107007
UR - https://doi.org/10.1016/j.rpth.2026.107007
SN - 2475-0379
ER -